Table of Contents

1 Industry Overview

• 1.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Chemotherapy-Induced Nausea and Vomiting Drugs
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Chemotherapy-Induced Nausea and Vomiting Drugs Market by Type

• 3.1 By Type
  • 3.1.1 Existing Drugs
  • 3.1.2 Akynzeo (Netupitant-Palonosetron FDC)
  • 3.1.3 Aloxi (Palonosetron)
  • 3.1.4 Emend (Aprepitant)
  • 3.1.5 Kytril Generic (Granisetron)
  • 3.1.6 Zofran Generic (Ondansetron)
  • 3.1.7 Pipeline Drugs
  • 3.1.8 SUSTOL (Granisetron Injection extended release)
  • 3.1.9 Rolapitant
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.Chemotherapy-Induced Nausea and Vomiting Drugs Merck & Co., Inc. (Company Profile, Sales Data etc.)

• 4.2 GlaxoSmithKline plc (Company Profile, Sales Data etc.)
• 4.3 Tesaro, Inc. (Company Profile, Sales Data etc.)
• 4.4 Helsinn Group (Company Profile, Sales Data etc.)
• 4.5 F. Hoffmann-La Roche Ltd. (Company Profile, Sales Data etc.)
• 4.6 Heron Therapeutics, Inc. (Company Profile, Sales Data etc.)
• 4.7 Dr. Reddy's Laboratories Ltd. (Company Profile, Sales Data etc.)
• 4.8 Acacia Pharma (Company Profile, Sales Data etc.)
• 4.9 Sun Pharmaceutical Industry Ltd. (Company Profile, Sales Data etc.)
• 4.10 Otsuka Holdings Co., Ltd. (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Serotonin Receptor Antagonists
  • 6.1.2 Demand in NK1 Receptor Antagonists
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Chemotherapy-Induced Nausea and Vomiting Drugs

Table Application Segment of Chemotherapy-Induced Nausea and Vomiting Drugs

Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market 2013-2024, by Application, in USD Million

Table Major Company List of Existing Drugs

Table Major Company List of Akynzeo (Netupitant-Palonosetron FDC)

Table Major Company List of Aloxi (Palonosetron)

Table Major Company List of Emend (Aprepitant)

Table Major Company List of Kytril Generic (Granisetron)

Table Major Company List of Zofran Generic (Ondansetron)

Table Major Company List of Pipeline Drugs

Table Major Company List of SUSTOL (Granisetron Injection extended release)

Table Major Company List of Rolapitant

Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market 2013-2018, by Type, in USD Million

Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market 2013-2018, by Type, in Volume

Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast 2019-2024, by Type, in USD Million

Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast 2019-2024, by Type, in Volume

Table Merck & Co., Inc. Overview List

Table Chemotherapy-Induced Nausea and Vomiting Drugs Business Operation of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table GlaxoSmithKline plc Overview List

Table Chemotherapy-Induced Nausea and Vomiting Drugs Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Tesaro, Inc. Overview List

Table Chemotherapy-Induced Nausea and Vomiting Drugs Business Operation of Tesaro, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Helsinn Group Overview List

Table Chemotherapy-Induced Nausea and Vomiting Drugs Business Operation of Helsinn Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table F. Hoffmann-La Roche Ltd. Overview List

Table Chemotherapy-Induced Nausea and Vomiting Drugs Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Heron Therapeutics, Inc. Overview List

Table Chemotherapy-Induced Nausea and Vomiting Drugs Business Operation of Heron Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Dr. Reddy's Laboratories Ltd. Overview List

Table Chemotherapy-Induced Nausea and Vomiting Drugs Business Operation of Dr. Reddy's Laboratories Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Acacia Pharma Overview List

Table Chemotherapy-Induced Nausea and Vomiting Drugs Business Operation of Acacia Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sun Pharmaceutical Industry Ltd. Overview List

Table Chemotherapy-Induced Nausea and Vomiting Drugs Business Operation of Sun Pharmaceutical Industry Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Otsuka Holdings Co., Ltd. Overview List

Table Chemotherapy-Induced Nausea and Vomiting Drugs Business Operation of Otsuka Holdings Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue 2013-2018, by Company, in USD Million

Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue Share, by Company, in USD Million

Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume 2013-2018, by Company, in Volume

Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Chemotherapy-Induced Nausea and Vomiting Drugs Demand Forecast 2019-2024, by Application, in USD Million

Table Chemotherapy-Induced Nausea and Vomiting Drugs Demand Forecast 2019-2024, by Application, in Volume

Table Chemotherapy-Induced Nausea and Vomiting Drugs Production 2013-2018, by Region, in USD Million

Table Chemotherapy-Induced Nausea and Vomiting Drugs Production 2013-2018, by Region, in Volume

Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market 2013-2018, by Region, in USD Million

Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share 2013-2018, by Region, in USD Million

Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market 2013-2018, by Region, in Volume

Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share 2013-2018, by Region, in Volume

Table North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2013-2018, by Country, in USD Million

Table North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2013-2018, by Country, in Volume

Table Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2013-2018, by Country, in USD Million

Table Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2013-2018, by Country, in Volume

Table South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2013-2018, by Country, in USD Million

Table South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2013-2018, by Country, in Volume

Table Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast 2019-2024, by Region, in USD Million

Table Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Growth 2013-2018, by Type, in USD Million

Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Growth 2013-2018, by Type, in Volume

Figure North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Concentration, in 2018

Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Market Concentration, in 2018

Figure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs MMarket Concentration, in 2018

Figure South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Concentration, in 2018

Figure Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Concentration, in 2018

Figure Chemotherapy-Induced Nausea and Vomiting Drugs Demand in Serotonin Receptor Antagonists, 2013-2018, in USD Million

Figure Chemotherapy-Induced Nausea and Vomiting Drugs Demand in Serotonin Receptor Antagonists, 2013-2018, in Volume

Figure Chemotherapy-Induced Nausea and Vomiting Drugs Demand in NK1 Receptor Antagonists, 2013-2018, in USD Million

Figure Chemotherapy-Induced Nausea and Vomiting Drugs Demand in NK1 Receptor Antagonists, 2013-2018, in Volume

Figure North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2013-2018, in USD Million

Figure North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2013-2018, in Volume

Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2013-2018, in USD Million

Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2013-2018, in Volume

Figure South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2013-2018, in USD Million

Figure South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview

Snapshot
The global Chemotherapy-Induced Nausea and Vomiting Drugs market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Chemotherapy-Induced Nausea and Vomiting Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Existing Drugs
Akynzeo (Netupitant-Palonosetron FDC)
Aloxi (Palonosetron)
Emend (Aprepitant)
Kytril Generic (Granisetron)
Zofran Generic (Ondansetron)
Pipeline Drugs
SUSTOL (Granisetron Injection extended release)
Rolapitant
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Merck & Co., Inc.
GlaxoSmithKline plc
Tesaro, Inc.
Helsinn Group
F. Hoffmann-La Roche Ltd.
Heron Therapeutics, Inc.
Dr. Reddy's Laboratories Ltd.
Acacia Pharma
Sun Pharmaceutical Industry Ltd.
Otsuka Holdings Co., Ltd.
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Serotonin Receptor Antagonists
NK1 Receptor Antagonists
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)